The Dual Role of Polyamines: Promise and Peril Uncovered by Tokyo University of Science
Researchers at Tokyo University of Science (TUS) have made a groundbreaking discovery that sheds light on the complex relationship between polyamines—small organic compounds celebrated for their anti-aging properties—and cancer progression. Polyamines, including putrescine, spermidine, and spermine, are naturally occurring molecules essential for cell growth, DNA stability, and protein synthesis. They have gained popularity in supplements promoted for extending lifespan and promoting cellular health through autophagy, the body's recycling process.
Led by Associate Professor Kyohei Higashi from TUS's Faculty of Pharmaceutical Sciences, the study reveals how these same compounds can fuel cancer cell proliferation through distinct molecular pathways. This finding, published in the Journal of Biological Chemistry, challenges the unbridled enthusiasm for polyamine-rich diets or supplements and opens doors to targeted cancer therapies.
What Are Polyamines? Building Blocks of Life with Anti-Aging Potential
Polyamines are polycations found in all living organisms, playing crucial roles in stabilizing DNA, RNA, and cell membranes. Spermidine, in particular, has been hailed as a 'geroprotector' because it induces autophagy—the process where cells degrade and recycle damaged components—leading to improved mitochondrial function and longevity in model organisms like yeast, worms, and mice. Human studies suggest diets rich in polyamines from foods like soybeans, wheat germ, and aged cheese correlate with lower age-related disease risk.
In Japan, where longevity research is a national priority amid an aging population—over 29% of citizens are 65+ as of 2025—polyamine supplements have surged in popularity. TUS's pharmaceutical sciences department, known for its cutting-edge biochemistry work, sought to bridge the gap between these benefits and observed elevations of polyamines in tumor tissues.
The Cancer Connection: Elevated Polyamines in Tumors
Cancer cells exhibit markedly higher polyamine levels, fueling rapid division and metastasis. Enzymes like ornithine decarboxylase (ODC), which synthesize polyamines, are often overexpressed in malignancies. While blocking polyamine synthesis has shown promise in preclinical models, clinical translation has been limited due to toxicity in normal cells. The TUS breakthrough identifies why: polyamines act differently based on cellular context.
The original TUS study used human cancer cell lines to deplete polyamines pharmacologically, then selectively restore them with spermidine. This revealed selective inhibition of cancer growth without broadly harming normal cells.
Decoding the Mechanism: eIF5A Isoforms Take Center Stage
At the heart of the discovery are two isoforms of eukaryotic translation initiation factor 5A (eIF5A): eIF5A1 and eIF5A2. These proteins, sharing 84% amino acid identity, differ critically in function. eIF5A requires hypusination—a unique post-translational modification using spermidine—to become active (eIF5AHyp).
| Aspect | eIF5A1 (Normal Cells) | eIF5A2 (Cancer Cells) |
|---|---|---|
| Primary Activation | Hypusination by spermidine | Polyamine-stimulated synthesis (unhypusinated) |
| Key Pathway | Autophagy → Mitochondrial health | Translational control → Glycolysis & proliferation |
| Regulator | Not miR-6514-5p | Suppressed by miR-6514-5p, blocked by polyamines |
| Outcome | Anti-aging, longevity | Tumor growth, malignancy |
In healthy cells, polyamines hypusinate eIF5A1, promoting autophagy. In cancer, they boost unhypusinated eIF5A2 (eIF5A2uhyp) synthesis by antagonizing microRNA miR-6514-5p, which normally suppresses eIF5A2 mRNA translation.
Advanced Proteomics Reveal Cancer-Specific Protein Shifts
TUS employed high-resolution mass spectrometry to profile over 6,700 proteins in polyamine-manipulated cancer cells. Key upregulated targets included eIF5A2 and five ribosomal proteins: RPS27A, RPL36AL, RPL22L1, RPL10, and others linked to poor prognosis. These changes favored glycolysis—the Warburg effect—over oxidative phosphorylation, enabling rapid energy for tumor expansion.
- RPS27A: Involved in ubiquitin pathways, overexpressed in aggressive cancers.
- RPL36AL and RPL22L1: Enhance translational efficiency for oncogenes.
- Overall: eIF5A2 uniquely decodes specific mRNAs for proliferation.
Silencing eIF5A1 or eIF5A2 yielded distinct proteomic profiles, confirming non-redundant roles.
Photo by User Untitled on Unsplash
Therapeutic Horizons: Targeting eIF5A2 for Selective Cancer Treatment
"The interaction between eIF5A2 and ribosomes, which regulates cancer progression, is a selective target for cancer treatment," states Dr. Higashi. Strategies could include miR-6514-5p mimics to suppress eIF5A2 or inhibitors of polyamine-eIF5A2 binding. Combined with existing polyamine synthesis inhibitors like DFMO (difluoromethylornithine), this offers precision without compromising anti-aging benefits.
In Japan, where cancer incidence rises with aging (1.5 million new cases yearly), such research aligns with national initiatives like the Cancer Moonshot program, fostering collaborations between universities and pharma firms.
Explore research jobs advancing these frontiers at institutions like TUS.
Cautions for Anti-Aging Enthusiasts: Context Matters
While spermidine supplements show promise in trials for cardiovascular health and neurodegeneration, TUS warns of risks in cancer-prone individuals. Elevated polyamines may accelerate dormant tumors. Clinical guidelines recommend screening before long-term use, especially in Japan's supplement-savvy market.
ScienceDaily coverage emphasizes: benefits in healthy tissues via eIF5A1, dangers via eIF5A2 in malignant ones.
Tokyo University of Science: A Hub for Innovative Pharma Research
TUS, founded in 1881, ranks among Japan's top private universities for science and engineering. Its Faculty of Pharmaceutical Sciences excels in biochemistry and drug discovery, with over 90 publications from Dr. Higashi alone. This breakthrough exemplifies TUS's commitment to translational research, supported by MEXT grants and industry partnerships.
In higher education, TUS attracts global talent; consider Japan university jobs or professor positions in pharma sciences.
Broader Implications for Global Aging and Oncology Research
Japan's super-aging society (world's oldest population) drives such studies, but findings resonate globally. Polyamine modulation could personalize anti-aging interventions, integrating genomics for eIF5A2 risk stratification. Ongoing trials explore spermidine in Alzheimer's, but now with cancer caveats.
Future Outlook: From Bench to Bedside at TUS
TUS plans in vivo models and miR-6514-5p therapeutics. Collaborations with Keio and Tokyo University could accelerate. For aspiring researchers, career advice on CVs for such competitive fields is invaluable.
Photo by Andrey Khoviakov on Unsplash
Career Opportunities in Japan's Cancer and Anti-Aging Research Landscape
This TUS discovery highlights booming demand for experts in translational oncology. Japan invests ¥100 billion+ annually in cancer R&D. Opportunities abound in faculty roles, research assistants, and postdocs. Platforms like AcademicJobs.com connect talents to TUS-like institutions.
- PhD in biochemistry/pharmacology: Ideal for eIF5A studies.
- Postdoc fellowships: MEXT, JSPS funding.
- Industry links: Pharma giants like Takeda seek polyamine experts.
Conclusion: Balancing Longevity and Oncology Insights
TUS's polyamines breakthrough redefines safe anti-aging strategies, urging caution with supplements while pinpointing eIF5A2 for therapies. As Japan leads in longevity science, global researchers can leverage these insights. Stay informed via Rate My Professor, pursue higher ed jobs, and access career advice. For Japan-specific roles, visit university jobs or post a job.
